Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study. The Reykjavik study

Journal of Human Hypertension

Volumn 18, Issue 9, 2004, Pages 615-622

  Gudmundsson, L S ^a   Johannsson, M ^a   Thorgeirsson, G ^a,b   Sigfusson, N ^b   Sigvaldason, H ^b   Witteman, J C M ^c  

^a UNIVERSITY OF ICELAND   (Iceland)

^b Heart Preventive Clinic Reykjavik   (Iceland)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Confounding; Longitudinal study; Men; Treatment; Women

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; ICELAND; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; ICELAND; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 4544311036     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001725     Document Type: Article

References (32)

1. Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 2000; 85: 251-255.
2. Klag MJ et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18.
3. Mosterd A et al. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med 1999; 340: 1221-1227.
4. Burt VL et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
5. Hansson L, Lloyd A, Anderson P, Kopp Z. Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press 2002; 11: 35-45.
6. Collins R et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-838.
7. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265: 3255-3264.
8. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed) 1986; 293: 1145-1151.
9. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992; 304: 405-412.
10. Kannel WB, Sorlie P, McNamara PM. Prognosis after initial myocardial infarction: the Framingham study. Am J Cardiol 1979; 44: 53-59.
11. Sigurdsson E et al. Long-term prognosis of different forms of coronary heart disease: The Reykjavik Study. Int J Epidemiol 1995; 24: 58-68.
12. Thurmer HL, Lund-Larsen PG, Tverdal A. Is blood pressure treatment as effective in a population setting as in controlled trials? Results from a prospective study. J Hypertens 1994; 12: 481-490.
13. Sytkowski PA, D'Agostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Circulation 1996; 93: 697-703.
14. Andersson OK et al. Survival in treated hypertension: follow up study after two decades. BMJ 1998; 317: 167-171.
15. Miettinen OS. The need for randomization in the study of intended effects. Stat Med 1983; 2: 267-271.
16. Walker AM, Stampfer MJ. Observational studies of drug safety. Lancet 1996; 348: 489.
17. Grobbee DE, Hoes AW. Confounding and indication for treatment in evaluation of drug treatment for hypertension. BMJ 1997; 315: 1151-1154.
18. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Prevalence of coronary heart disease in Icelandic men 1968-1986. The Reykjavik Study. Eur Heart J 1993; 14: 584-591.
19. Jonsdottir LS, Sigfusson N, Sigvaldason H, Thorgeirsson G. Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study. Eur Heart J 1998; 19: 1011-1018.
20. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977; 31: 42-48.
21. Rose GA, Blackburn H. Cardiovascular population studies: Methods. World Health Organization: Geneva, 1966.
22. Rose GA, Blackburn H. Cardiovascular Survey Methods. WHO: Geneva, 1968.
23. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 1988; 41: 105-114.
24. Sigfusson N et al. Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ 1991; 302: 1371-1375.
25. Bjornsson OJ et al. Survey of serum lipid levels in Icelandic Men aged 34-61 years. An epidemiological and statistical evaluation. Acta Med Scand 1977; 616(Suppl): 1-150.
26. Sigurdsson E, Sigfusson N, Sigvaldason H, Thorgeirsson G. Silent ST-T changes in an epidemiologic cohort study - a marker of hypertension or coronary heart disease, or both: The Reykjavik study. J Am Coll Cardiol 1996; 27: 1140-1147.
27. Cox DR. Regression models and lifetables. J Roy Statist Soc 1972; 34: 187-220.
28. MacMahon S et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
29. Gebsky V, Leung O, McNeil D, Lunn D. Statistical package for interactive data analysis (SPIDA), 6th Edn. Statistical computing lab, Macquarie University, NSW Australia, 1992.
30. Fahey TP, Peters TJ. What constitutes controlled hypertension? Patient based comparison of hypertension guidelines. BMJ 1996; 313: 93-96.
31. Psaty BM et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 1999; 47: 749-754.
32. Sigfusson N. Hypertension in middle-aged men. Acta Med Scand 1986; 710(Suppl): 1-131.